VC firms
In today's (and tomorrow's) economic environment, clarity is currency that becomes invaluable when managing capital and assets. DS9 Capital's extensive economic and market research, coupled with historical track record of performance, underpins actionable insights actively leveraged to create and execute on yield opportunities in bear, bull, or sideways markets.
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| OrchestraRx | orchestrarx.com | |||
| Javolin.com | javolin.com |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 22, 2022 | Investor Funding for Minority-Owned Startups Shows Significant Growth | According to Crunchbase, black startup founders raised a record $1.8 billion in 2021, 80% more than the $1 billion raised in all of 2020—but still less than 1.5% of all startup funding for the period. What’s necessary is for entrepreneurs t... |
| Mar 8, 2022 | Therapeutic Transparency Essential to Solving America’s Rising Rx Expenses | In recent years, 41 drugs increased more than 100% in price in the US, including the widely used antidepressant Prozac, which went up 879%. There are people making $90,000 a year who have difficulties paying for medicine. How can lesser-pai... |
| Feb 28, 2022 | Venture Capital Funding Grows, But Most Startups Left Out | Fewer than 5% of all U.S. startups receive any VC funding. If you are an entrepreneur, don’t be fooled by lofty promises from VCs who will take the company away from you. It may appear to you that the grass is greener over on the VC and PE ... |
| Feb 16, 2022 | The Elusive Healthcare Goal: Equality for People of Color | Clinical trials have historically tended to take place in larger cities, with some 50% of FDA trials being conducted within one to two percent of all US zip codes. Championing equity in healthcare leads to a focus on cultural competency, wh... |
| Feb 7, 2022 | With New White House Directives, Some Startups Could Compete for Government Contracts | A small disadvantaged business is defined as a startup company that is at least 51% owned by one or more individuals who are both socially and economically disadvantaged. To grow, a business must be able to attract investment. Getting an SD... |
| Jan 26, 2022 | Startups Seek Deep-Pocket Investors; but Are There Any That Care? | One of the flaws of today’s approach to investing is that startups generally lack the level of return that most venture capitalists want to see before they invest. Not many [institutional investors] are focusing on building companies that h... |
| Oct 11, 2021 | Investing in Start-Ups is About Sharing Vision, Expertise | Americans filed the paperwork to start 4.3 million businesses, which according to the U.S. Census Bureau, is a 24% increase from the previous year. It’s important to look for a finance provider offering guidance on insurance, legal and regu... |
| Jul 28, 2021 | Institutional Bias Blocks Underrepresented Businesses from Venture Capital, Private Equity Bonanza | Corporate America is losing millions of dollars in potential investment by not looking at small- and medium-sized business. America needs companies to play matchmaker between capital investors and underrepresented businesses, especially tho... |
Reviews 0
FAQ about DS9 Capital
How many startups has DS9 Capital invested in?
DS9 Capital has 3 portfolio companies on Parsers VC, among them OrchestraRx and Javolin.com.
What has the press written about DS9 Capital?
Parsers VC has collected 9 articles mentioning DS9 Capital, among them “Investor Funding for Minority-Owned Startups Shows Significant Growth” (Mar 22, 2022) and “Therapeutic Transparency Essential to Solving America’s Rising Rx Expenses” (Mar 8, 2022).
Is DS9 Capital still active?
Yes, DS9 Capital is active; its latest activity on Parsers VC dates from Feb 11, 2026.